Search

Author/Creator Fuchida, Shin-ichi

1. Monocyte or white blood cell counts and β2 microglobulin predict the durable efficacy of daratumumab with lenalidomide. (December 2022)

Authors:
Shimazu, Yutaka; Kanda, Junya; Kaneko, Hitomi; Imada, Kazunori; Yamamura, Ryosuke; Kosugi, Satoru; Shimura, Yuji; Ito, Tomoki; Fuchida, Shin-ichi; Uchiyama, Hitoji; Fukushima, Kentaro; Yoshihara, Satoshi; Hanamoto, Hitoshi; Tanaka, Hirokazu; Uoshima, Nobuhiko; Ohta, Kensuke; Yagi, Hideo; Shibayam...
Journal:
Therapeutic advances in hematology
Issue:
Volume 13(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Pretreatment serum level of interleukin-6 predicts carfilzomib-induced hypertension in relapsed/refractory multiple myeloma. Issue 7 (7th June 2022)

Authors:
Muramatsu, Ayako; Kobayashi, Tsutomu; Kawaji-Kanayama, Yuka; Uchiyama, Hitoji; Sasaki, Nana; Uoshima, Nobuhiko; Nakao, Mitsushige; Takahashi, Ryoichi; Shimura, Kazuho; Kaneko, Hiroto; Kiyota, Miki; Wada, Katsuya; Chinen, Yoshiaki; Hirakawa, Koichi; Fuchida, Shin-ichi; Shimazaki, Chihiro; Mizutani...
Journal:
Leukemia & lymphoma
Issue:
Volume 63:Issue 7(2022)
Page Start:
1678
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Real-world effectiveness and safety analysis of carfilzomib–lenalidomide–dexamethasone and carfilzomib–dexamethasone in relapsed/refractory multiple myeloma: a multicenter retrospective analysis. (June 2022)

Authors:
Onda, Yoshiyuki; Kanda, Junya; Kaneko, Hitomi; Shimura, Yuji; Fuchida, Shin-ichi; Nakaya, Aya; Itou, Tomoki; Yamamura, Ryosuke; Tanaka, Hirokazu; Shibayama, Hirohiko; Shimazu, Yutaka; Uchiyama, Hitoji; Yoshihara, Satoshi; Adachi, Yoko; Matsuda, Mitsuhiro; Hanamoto, Hitoshi; Uoshima, Nobuhiko; Kos...
Journal:
Therapeutic advances in hematology
Issue:
Volume 13(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Retrospective analysis of primary plasma cell leukemia in Kansai Myeloma Forum registry. (2018)

Authors:
Nakaya, Aya; Yagi, Hideo; Kaneko, Hitomi; Kosugi, Satoru; Kida, Toru; Adachi, Yoko; Shibayama, Hirohiko; Kohara, Takae; Kamitsuji, Yuri; Fuchida, Shin-ichi; Uoshima, Nobuhiko; Kawata, Eri; Uchiyama, Hitoji; Shimura, Yuji; Takahashi, Takayuki; Urase, Fumiaki; Ohta, Kensuke; Hamada, Tsuneyoshi; Miy...
Journal:
Leukemia research reports
Issue:
Volume 10(2018)
Page Start:
7
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Second primary malignancy after rituximab-containing immunochemotherapy for diffuse large B cell lymphoma. Issue 14 (5th December 2020)

Authors:
Chinen, Yoshiaki; Tanba, Kazuna; Takagi, Ryo; Uchiyama, Hitoji; Uoshima, Nobuhiko; Shimura, Kazuho; Fuchida, Shin-ichi; Kiyota, Miki; Nakao, Mitsushige; Tsukamoto, Taku; Shimura, Yuji; Kobayashi, Tsutomu; Horiike, Shigeo; Wada, Katsuya; Shimazaki, Chihiro; Kaneko, Hiroto; Kobayashi, Yutaka; Taniw...
Journal:
Leukemia & lymphoma
Issue:
Volume 61:Issue 14(2020)
Page Start:
3378
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗